Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Fludeoxyglucose F-18 Injection, Downstate Clincal PET Center - The Meth. Med. Ctr. of IL. NDA 20-306 6/2/00 6/9/00 6/9/00 6/4/01 Fludeoxyglucose Indications: (a)Assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. (b) Assessment of patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging, for the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function. Fludeoxyglucose F 18 Injection, Weill Medical, Approval | Fludeoxyglucose F 18 Injection, North Shore LIJ Research, Approval | Fludeoxyglucose F18 Injection, North Shore/LIJ, Manufacturing Change | Fludeoxyglucose F18 Injection, Weill Medical College, Manufacturing Change ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com